The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis
Open accessAbstract
Objective: To evaluate the frequency of visual manifestations at presentation in an Italian population‐based cohort of patients with biopsy‐proven giant cell arteritis (GCA), and to investigate predictors for the development of permanent visual loss. Methods: We identified 136 Reggio Emilia (Italy) residents with biopsy‐proven GCA diagnosed between 1986 and 2002. Medical records of these 136 patients were reviewed, and demographic, clinical, and laboratory data were collected. Multivariate analysis with multiple logistic regression models was performed to identify the best predictors of visual loss. Results: Visual manifestations developed in 41 patients (30.1%). Partial or total visual loss was observed in 26 patients (19.1%). Anterior ischemic optic neuropathy was seen in 24 patients, and 2 patients had central retinal artery occlusion. Unilateral vision loss occurred in 19 patients, and bilateral visual loss in 7. In 25 patients, visual loss developed before glucocorticoid therapy for GCA was started. The age at disease onset was significantly higher in patients with permanent visual loss compared with those without it. The frequency of systemic signs/symptoms and erythrocyte sedimentation rate (ESR) and C‐reactive protein values at diagnosis were significantly lower in patients with permanent visual loss. By multivariate logistic regression, the only statistically significant predictor for the development of permanent visual loss was the absence of high levels of ESR at diagnosis (tertile 2: Odds ratio [OR] 0.08; tertile 3: OR 0.11). Other predictors included in the model were the absence of systemic manifestations (OR 0.24), an older age at disease diagnosis (quintile 5: OR 5.60), and the presence of an elevated platelet count at diagnosis (OR 4.99), however they were only of borderline statistical significance. Conclusion: The proportion of Italian patients with GCA that developed visual loss was similar to that reported from other countries. The patients with low inflammatory response had a higher risk of visual loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyalgia Rheumatica and Giant-Cell Arteritis
Salvarani, C., Cantini, F., Boiardi, L., & Hunder, G. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011913 · Cited by 1,352
Self-citationOcular manifestations of giant cell arteritis
Hayreh, S. S., Podhajsky, P. A., & Zimmerman, B. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80192-5 · Cited by 571
Temporal Arteritis: A 25-Year Epidemiologic, Clinical, and Pathologic Study
HUSTON, K. A., HUNDER, G. G., LIE, J. T., KENNEDY, R. H., & ELVEBACK, L. R. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-2-162 · Cited by 547
González-Gay, M. A., Blanco, R., Rodríguez-Valverde, V., Martínez-Taboada, V. M., Delgado-Rodriguez, M., Figueroa, M., & Uriarte, E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199808)41:8<1497::aid-art22>3.0.co;2-z · Cited by 408
Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients
González-Gay, M. A., García-Porrúa, C., Llorca, J., Hajeer, A. H., Brañas, F., Dababneh, A., González-Louzao, C., Rodriguez-Gil, E., Rodríguez-Ledo, P., & R. Ollier, W. E. (2000) · Medicine · doi:10.1097/00005792-200009000-00001 · Cited by 400
Visual Prognosis in Giant Cell Arteritis
Aiello, P. D., Trautmann, J. C., McPhee, T. J., Kunselman, A. R., & Hunder, G. G. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31608-8 · Cited by 388
Hayreh, S. S., Zimmerman, B., & Kardon, R. H. (2002) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2002.800403.x · Cited by 266
Hernández-Rodríguez, J., Segarra, M., Vilardell, C., Sánchez, M., García-Martínez, A., Esteban, M.-J., Grau, J. M., Urbano-Márquez, A., Colomer, D., Kleinman, H. K., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066907.83923.32 · Cited by 191
Risk Factors for Cranial Ischemic Complications in Giant Cell Arteritis
Nesher, G., Berkun, Y., Mates, M., et al. (2004) · Medicine · doi:10.1097/01.md.0000119761.27564.c9 · Cited by 148
Salvarani, C., Macchioni, P., Tartoni, P. L., Rossi, F., Baricchi, R., CASTRI, C. L., Chiaravalloti, F., & Portioli, I. (1987) · PubMed · Cited by 122
Self-citationCid, M. C., Hernández‐Rodríguez, J., Esteban, M., Cebrián, M., Gho, Y. S., Font, C., Urbano-Márquez, A., Grau, J. M., & Kleinman, H. K. (2002) · Circulation · doi:10.1161/01.cir.0000030185.67510.c0 · Cited by 112
Cited by
Salem, J.-E., Manouchehri, A., Moey, M., Lebrun-Vignes, B., Bastarache, L., Pariente, A., Gobert, A., Spano, J.-P., Balko, J. M., Bonaca, M. P., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30608-9 · Cited by 1,271
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Dejaco, C., Ramiro, S., Duftner, C., Besson, F. L., Bley, T. A., Blockmans, D., Brouwer, E., Cimmino, M. A., Clark, E., Dasgupta, B., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212649 · Cited by 963
Self-citationPolymyalgia rheumatica and giant-cell arteritis
Salvarani, C., Cantini, F., & Hunder, G. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61077-6 · Cited by 767
Self-citationPolymyalgia Rheumatica and Giant Cell Arteritis
Ettlinger, R. E., Hunder, G. G., & Ward, L. E. (1978) · Annual Review of Medicine · doi:10.1146/annurev.me.29.020178.000311 · Cited by 687
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review
Buttgereit, F., Dejaco, C., Matteson, E. L., & Dasgupta, B. (2016) · JAMA · doi:10.1001/jama.2016.5444 · Cited by 496
Metadata
- Authors
- Salvarani, C., Cimino, L., Macchioni, P., Consonni, D., Cantini, F., Bajocchi, G., Pipitone, N., Catanoso, M. G., & Boiardi, L.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2005-04-07
- Volume
- 53
- Issue
- 2
- Pages
- 293-297
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2083407120
- Cited by
- 284
- References
- 11
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.